Originator Organization A-Alpha Bio, Inc.Startup |
Active Organization A-Alpha Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | A-Alpha Bio, Inc.Startup | 13 Jun 2024 |